Nanomedicine shows promise in early cancer trials
Technology Review reports: ‘Programmable nanoparticles have shown promise in early cancer trials, and may finally fulfill the promise of nanomedicine.’
Technology Review reports: ‘Programmable nanoparticles have shown promise in early cancer trials, and may finally fulfill the promise of nanomedicine.’